IGHMBP2 and Spinal muscular atrophy with respiratory distress type 1: Sensory involvement and autonomic dysfunction, including excessive sweating, tachycardia, constipation and bladder dysfunction, have been described in patients with SMARD1 but also in patients with CMT2S due to IGHMBP2 mutations.